Medipacs Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

Medipacs General Information

Description

Developer of non-mechanical infusion pumps designed for the delivery of drugs. The company's devices are non-mechanical infusion pumps used to deliver drugs, including biologic medications, insulin, hormones, fertility drugs, anti-coagulation drugs, and pain medication, enabling medical professionals to treat people and animals for post-surgical pain and other needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2100 North Wilmot Road
  • Suite 310
  • Tucson, AZ 85712
  • United States
+1 (520)
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Corporate Office
  • 2100 North Wilmot Road
  • Suite 310
  • Tucson, AZ 85712
  • United States
+1 (520)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipacs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Feb-2022 Completed Generating Revenue
10. Equity Crowdfunding 23-Feb-2021 Cancelled Generating Revenue
9. Later Stage VC (Series C) 01-Oct-2015 Completed Generating Revenue
8. Later Stage VC (Series B) 18-Aug-2014 Completed Generating Revenue
7. Later Stage VC 01-Sep-2010 Completed Generating Revenue
6. Accelerator/Incubator 11-Jun-2009 Completed Product Development
5. Later Stage VC (Series A3) 14-May-2009 Completed Product Development
4. Grant 01-Jan-2009 Completed Startup
3. Early Stage VC (Series A2) 27-May-2008 $1.66M $1.78M Completed Startup
2. Angel (individual) 01-Jan-2008 $114K $114K Completed Startup
To view Medipacs’s complete valuation and funding history, request access »

Medipacs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A3
Series A2 5,181,958 $0.001000 8% $0.32 $0.32 1x $0.32 9.81%
Series A1 759,233 $0.001000 8% $0.15 $0.15 1x $0.15 1.44%
To view Medipacs’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Medipacs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-mechanical infusion pumps designed for the delivery of drugs. The company's devices are non-mechanical
Drug Delivery
Tucson, AZ
2 As of 2018

Luzern, Switzerland
 

Viby Sj, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medipacs Competitors (9)

One of Medipacs’s 9 competitors is CeQur Simplicity, a Venture Capital-Backed company based in Luzern, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CeQur Simplicity Venture Capital-Backed Luzern, Switzerland
Subcuject Venture Capital-Backed Viby Sj, Denmark
Haselmeier Corporate Backed or Acquired Stuttgart, Germany
SHL Medical Private Equity-Backed Zug, Switzerland
Noble International (Orlando) Corporate Backed or Acquired Orlando, FL
You’re viewing 5 of 9 competitors. Get the full list »

Medipacs Patents

Medipacs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2906274-A1 Smart polymer materials with excess reactive molecules Inactive 14-Mar-2012
US-10000605-B2 Smart polymer materials with excess reactive molecules Active 14-Mar-2012
US-20150094448-A1 Smart polymer materials with excess reactive molecules Active 14-Mar-2012
EP-2847249-A1 Smart polymer materials with excess reactive molecules Inactive 14-Mar-2012
EP-2847249-A4 Smart polymer materials with excess reactive molecules Inactive 14-Mar-2012 C08G59/22
To view Medipacs’s complete patent history, request access »

Medipacs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medipacs Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
EvoNexus Accelerator/Incubator Minority
Hot Ventures Venture Capital Minority
Keshif Ventures Venture Capital Minority
Arizona Center for Innovation Accelerator/Incubator
Desert Angels Angel Group Minority
You’re viewing 5 of 9 investors. Get the full list »

Medipacs FAQs

  • When was Medipacs founded?

    Medipacs was founded in 2004.

  • Where is Medipacs headquartered?

    Medipacs is headquartered in Tucson, AZ.

  • What is the size of Medipacs?

    Medipacs has 2 total employees.

  • What industry is Medipacs in?

    Medipacs’s primary industry is Drug Delivery.

  • Is Medipacs a private or public company?

    Medipacs is a Private company.

  • What is Medipacs’s current revenue?

    The current revenue for Medipacs is .

  • How much funding has Medipacs raised over time?

    Medipacs has raised $11.6M.

  • Who are Medipacs’s investors?

    EvoNexus, Hot Ventures, Keshif Ventures, Arizona Center for Innovation, and Desert Angels are 5 of 9 investors who have invested in Medipacs.

  • Who are Medipacs’s competitors?

    CeQur Simplicity, Subcuject, Haselmeier, SHL Medical, and Noble International (Orlando) are some of the 9 competitors of Medipacs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »